3 not yet recruiting, 1 completed. 2 Phase 3, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 2 |
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Primary Hypercholesterolemia or Mixed Hyperlipidemia: new trials by email Literature Review of Primary Hypercholesterolemia or Mixed Hyperlipidemia trials Research Report on Primary Hypercholesterolemia or Mixed Hyperlipidemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia QLC7401, Placebo - Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 3 | Not yet recruiting | Qilu Pharmaceutical Co., Ltd. | 510 | 2026-03-05 | 2026-03-02 |
| QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C) QLC7401, Placebo - Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 3 | Not yet recruiting | Qilu Pharmaceutical Co., Ltd. | 780 | 2026-03-01 | 2026-03-04 |
| A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan Bempedoic acid 180 mg tablet - Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 4 | Completed | Daiichi Sankyo | 180 | 2025-04-01 | 2025-12-08 |
| Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol QLC7401, Placebo - Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 2 | Not yet recruiting | Qilu Pharmaceutical Co., Ltd. | 156 | 2025-02-01 | 2024-12-27 |
Hyperlipoproteinemia Type II (4)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Dyslipidemias (4) · Genetic Diseases, Inborn (4) · Hyperlipidemias (4) · Hyperlipoproteinemias (4) · Lipid Metabolism Disorders (4) · Lipid Metabolism, Inborn Errors (4) · Metabolic Diseases (4) · Metabolism, Inborn Errors (4) · Nutritional and Metabolic Diseases (4)
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid (1) · Tablets (1)
Qilu Pharmaceutical Co., Ltd. (3) · Daiichi Sankyo (1)
Taiwan (1)